Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
827.2 USD | +0.84% | +2.85% | +42.54% |
04:21pm | Eli Lilly: encouraging data for olomorasib | CF |
01:55pm | Structure Therapeutics' obesity drug meets main goal in mid-stage study | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.54% | 739B | |
+32.34% | 598B | |
-6.05% | 353B | |
+17.37% | 318B | |
+3.34% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+5.62% | 164B | |
+1.23% | 162B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Eli Lilly Reports Positive Trial Results for Crohn's Disease Treatment